---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027292"
form_type: "8-K"
ticker: null
cik: "0001394319"
company_name: "Tracon Pharmaceuticals, Inc."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:40:21.717256+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# TRACON receives Nasdaq deficiency notices for market value <$35M and bid price <$1.00

## Summary
- On June 8, 2023, TRACON received notices that its market value was below $35M and bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until December 5, 2023, to regain compliance with both Nasdaq listing rules.
- To regain compliance, market value must be >= $35M and bid price >= $1.00 for ten consecutive business days during the grace period.
- If not compliant by deadline, could face delisting; company may appeal or seek additional 180-day period for bid price via reverse stock split.
- TRACON is evaluating potential actions to regain compliance; no assurance of maintaining listing on Nasdaq.

## SEC filing metadata
- accession: 0000950170-23-027292
- form_type: 8-K
- cik: 0001394319
- company_name: Tracon Pharmaceuticals, Inc.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/0000950170-23-027292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/tcon-20230608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027292
- JSON: https://secwatch.observer/filing/0000950170-23-027292.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027292.txt

## Key facts
- Listing & Compliance Notices
  Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: 5550(b)(2) (the “Market Value Rule”), and (ii) for 30 consecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/0000950170-23-027292-index.htm
- Listing & Compliance Notices
  Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: market value
  - Rules: 5550(b)(2), 5810(c)(3)(C), 5810(c)(3)(A)
  source text: June 8, 2023, TRACON Pharmaceuticals, Inc. (the “Company”) received letters (the “Notices”) from the Listing Qualifications staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that (i) for 30 consecutive business days preceding the date of the Notices, the market value of the Company’s common stock was less than $35.0 million, which does not meet the requirement for continued listing on the Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “Market Value Rule”), and (ii) for 30 consecutive business days preceding the date of the Notices, t
  evidence_url: https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/0000950170-23-027292-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.